P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals

Autor: Maria Martire, Irene Samengo, Diego Currò, Pierluigi Navarra
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Agonist
Male
Purinergic P2X Receptor Antagonists
Settore BIO/14 - FARMACOLOGIA
medicine.drug_class
lcsh:Medicine
Stimulation
AMPA receptor
Pharmacology
H]D-aspartic acid release
Receptors
Presynaptic

Synaptic Transmission
Purinergic P2X Receptor Agonists
03 medical and health sciences
Glutamatergic
chemistry.chemical_compound
0302 clinical medicine
Trigeminal caudal nucleus
medicine
Animals
Nociceptive circuit
Receptors
AMPA

Receptor
AMPA receptors
030304 developmental biology
Nerve Endings
0303 health sciences
business.industry
lcsh:R
Antagonist
[3H]D-aspartic acid release
General Medicine
Central sensitization
Rats
Anesthesiology and Pain Medicine
chemistry
P2X7 receptor
NBQX
Neurology (clinical)
Receptors
Purinergic P2X7

business
[
Free nerve ending
Excitatory Amino Acid Antagonists
030217 neurology & neurosurgery
Research Article
Synaptosomes
Zdroj: The Journal of Headache and Pain
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-10 (2020)
Popis: Background Purine receptors play roles in peripheral and central sensitization and are associated with migraine headache. We investigated the possibility that ATP plays a permissive role in the activation of AMPA receptors thus inducing Glu release from nerve terminals isolated from the rat trigeminal caudal nucleus (TCN). Methods Nerve endings isolated from the rat TCN were loaded with [3H]D-aspartic acid ([3H]D-ASP), layered into thermostated superfusion chambers, and perfused continuously with physiological medium, alone or with various test drugs. Radioactivity was measured to assess [3H]D-ASP release under different experimental conditions. Results Synaptosomal [3H]D-ASP spontaneous release was stimulated by ATP and to an even greater extent by the ATP analogue benzoylbenzoylATP (BzATP). The stimulation of [3H]D-ASP basal release by the purinergic agonists was prevented by the selective P2X7 receptor antagonist A438079. AMPA had no effect on basal [3H]D-ASP release, but the release observed when synaptosomes were exposed to AMPA plus a purinoceptor agonist exceeded that observed with ATP or BzATP alone. The selective AMPA receptor antagonist NBQX blocked this “excess” release. Co-exposure to AMPA and BzATP, each at a concentration with no release-stimulating effects, evoked a significant increase in [3H]D-ASP basal release, which was prevented by exposure to a selective AMPA antagonist. Conclusions P2X7 receptors expressed on glutamatergic nerve terminals in the rat TCN can mediate Glu release directly and indirectly by facilitating the activation of presynaptic AMPA receptors. The high level of glial ATP that occurs during chronic pain states can promote widespread release of Glu as well as can increase the function of AMPA receptors. In this manner, ATP contributes to the AMPA receptor activation involved in the onset and maintenance of the central sensitization associated with chronic pain.
Databáze: OpenAIRE